Düsseldorf/Mumbay, November 18, 2013 – At CPhI in Mumbai, which is being held at the Bombay Exhibition Centre, Gerresheimer will be presenting new solutions for the fast-growing pharmaceutical industry in Asia at Stand V3 and A18 from December 3 up to 5. The comprehensive range of products extends from simple pharmaceutical vials to complex drug delivery systems.
60 percent of the people on our planet live in Asia. Greater prosperity and population growth have increased the significance of health care. Market researchers estimate that the pharmaceutical industry will experience vast growth in these markets in coming years. Gerresheimer specialises in safe and consumer friendly primary packaging products and is well positioned in Asia with its eight production facilities in India and China.
Gerresheimer’s portfolio of products covers pharmaceutical vials, complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application.
The Tubular Glass Division is presenting a range of prefillable syringes, including its flagship RTF® sterile syringes. Tubular glass is the input material for a comprehensive range of high quality pharmaceutical vials, ampoules and cartridges in numerous filling sizes and design variants.
Gerresheimer Plastic Packaging specializes in plastic packaging products for the pharma industry. Its comprehensive product portfolio extends from plastic packaging products for solid pharmaceuticals such as drugs and powders to containers for liquid drugs, including ophthalmic and rhinological applications.
The Moulded Glass division manufactures high-quality injection and infusion bottles as well as dropper and tablet bottles of various types, shapes and sizes in glass categories I, II and III.
Links to further information:
Gerresheimer Tubular Glass
Gerresheimer Moulded Glass
Gerresheimer Plastic Packaging
About Gerresheimer
Gerresheimer is an internationally leading manufacturer of high-quality specialty products made of glass and plastic for the global pharma and healthcare industry. Our comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. Together with our partners, we develop solutions which set standards and have role model status in their respective market sectors.
Our Group realizes revenues of more than one billion euros and has around 11,000 employees at 47 locations in Europe, North and South America and Asia. We use first-rate technologies, convincing innovations and targeted investments to systematically consolidate our strong market position.